Jobs / United States / Pfizer INC
Senior Director, US Medical Affairs, Obesity, MD
Pfizer INC · 🇺🇸 United States - New York - New York City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles1 certified filing for “PHARMACOMETRICIAN, DIRECTOR” (Medical Scientists, Except Epidemiologists) in PA: $170k–$170k, median $170k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
ROLE SUMMARY The Senior Medical Director, Berobenatide will provide strategic and scientific leadership for US Medical Affairs activities supporting berobenatide in obesity and obesity-related comorbid conditions. This role is accountable for shaping and executing the US medical strategy across the product lifecycle, with a strong emphasis on US medical affairs strategy, evidence generation, cross-functional coordination, and external scientific engagement. The role partners closely with Global Medical Affairs (GMAT), Commercial, Clinical Development, and Field Medical teams to ensure alignment between global strategy and US execution. As beronatide approaches launch and the obesity portfolio grows, this role may expand to include formal people leadership responsibilities. ROLE RESPONSIBILITIES • Lead strategic planning and execution of US Medical Affairs strategy for berobenatide in obesity and comorbid conditions. • Translate strategy into integrated medical tactics and coordinate cross-functional execution. • Ensures timely and appropriate management of the medical affairs budget and expenditure • Support and shape the US evidence generation strategy including Phase IV, RWE, and publication activities. • Ensures seamless and coordinated partnership with Field Medical leadership to achieve integration of insights into strategy development and execution • Participate in medical and promotional review committees ensuring scientific rigor and compliance. • Establishes new and grow existing critical external relationships with US thought leaders and professional societies for obesity. Provide input into medical engagement planning including advisory boards and scientific exchange. • Represent US Medical Affairs at national and international scientific congresses and conferences. • Manage key stakeholders including Global Medical Affairs (GMAT), Commercial teams, and other internal partners. • Contribute to future leadership needs as the portfolio and medical organization evolves. BASIC QUALIFICATIONS Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. • MD with 5+ years industry experience • Strong understanding of obesity or cardiometabolic care delivery across primary care, specialty care, and health systems (preferred) • Experience developing and leading integrated scientific engagement strategies across primary care, specialty care, health systems, professional societies, patient organizations, and other healthcare ecosystem stakeholders. • Demonstrated experience addressing identified medical, evidence, educational, or care-delivery gaps through evidence generation, scientific exchange, health-system collaboration, or field medical engagement. • Experience generating and communicating scientific evidence that may inform independent evidence reviews, clinical guidance discussions, and evidence-based clinical decision-making. • Experience designing stakeholder segmentation, prioritization, and scientific engagement models based on stakeholder expertise, role, scientific relevance, and documented information needs, including making strategic resource-allocation decisions across medical priorities. • Prior field medical leadership or substantial experience partnering with field medical teams, with demonstrated credibility among field medical colleagues and external scientific experts. • Experience establishing appropriately governed scientific collaborations with health systems, professional societies, academic institutions, patient organizations, or other healthcare ecosystem stakeh